References - Digestion Protocol

1. Hiraishi H, Sasai T, Oinuma T, Shimada T, Sugaya H, Terano A. "Polaprezinc protects gastric mucosal cells from noxious agents through antioxidant properties in vitro." Aliment Pharmacol Ther. 1999 Feb;13(2):261-9.

2. Furuta S, Suzuki M, Toyama S, Miwa M, Sano H. "Tissue distribution of polaprezinc in rats determined by the double tracer method." J Pharm Biomed Anal. 1999 Mar;19(3-4):453-61.

3. Suzuki H, Mori M, Seto K, Miyazawa M, Kai A, Suematsu M, Yoneta T, Miura S, Ishii H. "Polaprezinc attenuates the Helicobacter pylori-induced gastric mucosal leucocyte activation in Mongolian gerbils--a study using intravital videomicroscopy." Aliment Pharmacol Ther. 2001 May;15(5):715-25.

4. Korolkiewicz RP, Fujita A, Seto K, Suzuki K, Takeuchi K. "Polaprezinc exerts a salutary effect on impaired healing of acute gastric lesions in diabetic rats."  Dig Dis Sci. 2000 Jun;45(6):1200-9.

5. Corcoran BM, Ross RP, Fitzgerald GF, Stanton C.  "Comparative survival of probiotic lactobacilli spray-dried in the presence of prebiotic substances."  J Appl Microbiol. 2004;96(5):1024-39.    

6. Morelli L, Zonenschain D, Callegari ML, Grossi E, Maisano F, Fusillo M.  "Assessment of a new synbiotic preparation in healthy volunteers: survival, persistence of probiotic strains and its effect on the indigenous flora."  Nutr J. 2003 Oct 09;2(1):11.

7. Roller M, Rechkemmer G, Watzl B.  "Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats."  J Nutr. 2004 Jan;134(1):153-6.